Perineural Invasion Contributes to Tumor Recurrence and Worse Outcomes Following Curative-Intent Resection for Intrahepatic Cholangiocarcinoma
T. Wei,X.-F. Zhang,M. Weiss,I. Popescu,H.P. Marques,L. Aldrighetti,S.K. Maithel,C. Pulitano,T.W. Bauer,F. Shen,G.A. Poultsides,O. Soubrane,G. Martel,B.G. Koerkamp,E. Itaru,Y. Lv,T. Pawlik
DOI: https://doi.org/10.1016/j.hpb.2022.05.984
IF: 3.842
2022-01-01
HPB
Abstract:Introduction: There is limited evidence of the association of PNI with tumor recurrence, as well as survival following curative resection for ICC, especially among patients with early-stage disease (N0, AJCC T1-2). Methods: Patients undergoing curative-intent resection for ICC between 2000-2017 were identified from an international multi-institutional database. The relationship between PNI, clinicopathologic characteristics, and long-term survival were analyzed in the whole and early-stage cohort. Results: 1,095 total patients were included. PNI was present in 239(21.8%) patients. PNI was associated with worse disease-free survival(DFS)(median DFS: PNI 13.2 vs. no PNI 16.1 months,p=0.038) and overall survival(OS)(median OS: PNI 26.4 vs. no PNI 41.5 months,p<0.001) after surgical resection versus no PNI. On multivariable analysis, PNI remained an independent risk factor associated with reduced DFS(HR 1.5, 95%CI 1.1-2.1,p=0.019) and OS(HR 1.7, 95%CI 1.2-2.6,p=0.007). In patients with N0 disease(n=249) or AJCC T1-2 disease(n=981), PNI was consistently associated with shortened DFS(median DFS, N0: PNI 11.7 vs. no PNI 17.5 months, p=0.022; AJCC T1-2: PNI, 13.7 vs. no PNI, 16.6 months,p=0.019) and OS(median OS, N0: PNI 34.9 vs. no PNI 47.5 months, p=0.036; AJCC T1-2: PNI, 28.5 vs. no PNI, 45.7 months;p<0.001) versus no PNI, respectively, but not among patients with N1 or AJCC T3-4 disease. PNI was independently associated with worse DFS and OS among patients with early-stage N0 or AJCC T1-2 disease. Conclusions: PNI represents a major determinant of tumor recurrence and long-term survival among early-stage patients with N0 or AJCC T1-2 disease. PNI should be considered during postoperative follow-up strategies, as well as adjuvant therapies.